Drug Discovery World

NOVEMBER 14, 2022

Don’t forget to register for this free webinar, hosted by DDW and supported by Catalent, Early phase support for plasmid DNA supply helps secure future manufacturing for advanced therapies. The post Webinar: How to resolve barriers to CGT discovery appeared first on Drug Discovery World (DDW). Register for free. .

DNA 130

DNA Therapies Vaccine Production 130

Drug Discovery World

OCTOBER 17, 2022

One critical bottleneck in Cell and Gene Therapy (CGT) manufacturing is the production of high-quality plasmid DNA (pDNA), a vital building block for mRNA-based vaccines, viral vector-based cell, or gene therapies that require pDNA as a starting material. . It will take place on November 17, 2022, 3pm GMT, 4pm CET. Register for free. .

DNA 130

DNA Therapies Vaccine Production 130

Drug Discovery World

NOVEMBER 4, 2022

One critical bottleneck in Cell and Gene Therapy (CGT) manufacturing is the production of high-quality plasmid DNA (pDNA), a vital building block for mRNA-based vaccines, viral vector-based cell, or gene therapies that require pDNA as a starting material. . It will take place on November 17, 2022, 3pm GMT, 4pm CET. Register now.

DNA 130

DNA Therapies Vaccine Production 130

Drug Discovery World

NOVEMBER 23, 2022

One critical bottleneck in Cell and Gene Therapy (CGT) manufacturing is the production of high-quality plasmid DNA (pDNA), a vital building block for mRNA-based vaccines, viral vector-based cell or gene therapies that require pDNA as a starting material.

DNA 130

DNA Packaging Therapies Vaccine 130

Drug Discovery World

OCTOBER 24, 2022

This free webinar, hosted by DDW and supported by Catalent, will be presented by Matthias Craig, Senior Manager Product Development, Catalent. The post Webinar: Optimise plasmid production process and supply appeared first on Drug Discovery World (DDW). It will take place on November 17, 2022, 3pm GMT, 4pm CET.

Production 100

Production DNA Therapies Vaccine 100

Drug Discovery World

APRIL 17, 2024

This webinar will detail how Oxford Nanopore evaluated long-read nanopore sequencing as a comprehensive and sensitive QC method for rAAVs which is supporting internal research activities at AstraZeneca. The post DDW event focusses on rAAVs and long-read nanopore sequencing appeared first on Drug Discovery World (DDW).

DNA 246

DNA Packaging Virus International 246

Drug Discovery World

APRIL 16, 2024

This webinar will highlight how long-read nanopore sequencing as a comprehensive and sensitive QC method for rAAVs were evaluated — which is supporting internal research activities at AstraZeneca. A live Q&A session follows the webinar presentation.

Packaging 130

Packaging DNA Virus International 130

Drug Discovery World

MAY 8, 2024

This webinar will detail how Oxford Nanopore evaluated long-read nanopore sequencing as a comprehensive and sensitive QC method for rAAVs which is supporting internal research activities at AstraZeneca. appeared first on Drug Discovery World (DDW). The event will take place on 13 May, 4PM BST.

Therapies 173

Therapies DNA Packaging Virus 173

Drug Discovery World

JUNE 28, 2023

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” Join this free webinar to learn about the opportunities in mRNA drug discovery and development. An audience Q&A session with the presenters will follow the webinar presentation.

DNA 130

DNA Drugs Engineering Drug Development 130

Drug Discovery World

MAY 1, 2024

This webinar will detail how Oxford Nanopore evaluated long-read nanopore sequencing as a comprehensive and sensitive QC method for rAAVs which is supporting internal research activities at AstraZeneca. The post Uncovering packaging impurities with rAAV genome sequencing appeared first on Drug Discovery World (DDW).

Packaging 130

Packaging DNA Virus International 130

Drug Discovery World

APRIL 24, 2024

This webinar will detail how Oxford Nanopore evaluated long-read nanopore sequencing as a comprehensive and sensitive QC method for rAAVs which is supporting internal research activities at AstraZeneca. The post How rAAV genome sequencing uncovers transgene integrity appeared first on Drug Discovery World (DDW).

DNA 130

DNA Packaging Virus International 130

Drug Discovery World

JULY 5, 2023

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” Join this free webinar to learn about the opportunities in mRNA drug discovery and development. An audience Q&A session with the presenters will follow the webinar presentation.

DNA 130

DNA Engineering Drug Development Disease 130

Drug Discovery World

OCTOBER 31, 2022

One critical bottleneck in Cell and Gene Therapy (CGT) manufacturing is the production of high-quality plasmid DNA (pDNA), a vital building block for mRNA-based vaccines, viral vector-based cell, or gene therapies that require pDNA as a starting material. . It will take place on November 17, 2022, 3pm GMT, 4pm CET. Register for free. .

Therapies 130

Therapies DNA Vaccine Production 130

Drug Discovery World

OCTOBER 3, 2023

Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. Questions were fielded from the audience, which included: What analysis will be performed to evaluate host or other DNA contamination? Why are those important?

Therapies 130

Therapies Bioinformatics Packaging Molecular Biology 130

Drug Discovery World

JUNE 7, 2023

Hosted by DDW and sponsored by DNA Script, join us for this free-to-attend roundtable to learn about the biggest opportunities for the future of drug discovery and development. Is it true that the next era will belong to antibody drug conjugates? appeared first on Drug Discovery World (DDW).

DNA 130

DNA Clinical Trials Drugs Vaccine 130

The Pharma Data

JANUARY 6, 2021

Next-generation digital technologies are having an immense impact on the drug discovery process. The pharma industry is witnessing a steep rise in the use of AI-driven solutions in early-stage drug discovery, deep-learning technologies for compound screening, and lead identification and automation enhancements in the lab.

Cell Based Assays 52

Cell Based Assays Compound Screening Organic Chemistry DNA 52

Drug Discovery World

FEBRUARY 8, 2024

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. Questions were fielded from the audience, which included: What analysis will be performed to evaluate host or other DNA contamination? Why are those important?

Therapies 147

Therapies Bioinformatics Packaging Molecular Biology 147

Fierce BioTech

OCTOBER 26, 2023

The company has developed a disruptive DNA synthesis platform that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. The company has developed a disruptive DNA synthesis platform that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip.

DNA 52

DNA Bioinformatics Engineering Science 52

Drug Discovery World

SEPTEMBER 29, 2022

Challenges in outsourcing drug discovery. The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time. Alternatively, some targets require novel, innovative solutions that may not be accessible in conventional drug discovery labs. Opportunities, options, and outsourcing.

Small Molecule 130

Small Molecule Assay Development DNA Biochemical Assays 130

Drug Discovery World

AUGUST 19, 2024

In a webinar on 5 September, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, will present his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. The event is hosted by DDW and supported by Thermo Fisher Scientific.

Virus 130

Virus DNA Clinical Trials Engineering 130

Drug Discovery World

AUGUST 13, 2024

In this webinar, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, will present his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. The post Webinar: Adeno-associated virus vectors for gene therapy appeared first on Drug Discovery World (DDW).

Virus 130

Virus Therapies DNA Clinical Trials 130

Conversations in Drug Development Trends

JUNE 21, 2024

This year, Matt Cooper, PhD , our Executive Director, Therapeutic Strategy Lead, Oncology, attended and found the presentations around antibody-drug conjugates (ADCs) and tumor-infiltrating lymphocytes (TILs) to be of great interest to the future of oncology therapeutics. Interested in hearing more insights from Matt?

Clinical Trials 64

Clinical Trials Clinical Research Immune Response Therapies 64

Drug Discovery World

AUGUST 12, 2024

Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for next-generation antibody production. The post New webinar: Next-generation antibody discovery appeared first on Drug Discovery World (DDW).

DNA 130

DNA Immune Response Pharmaceuticals Production 130

Drug Discovery World

AUGUST 19, 2024

Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for next-generation antibody production. The event will feature Albert Zhang, Field Marketing & CRO Specialist at Fujifilm Wako.

DNA 130

DNA Immune Response Pharmaceuticals Production 130

Drug Discovery World

OCTOBER 23, 2023

The effect of several variables on the IVT reaction using different size DNA templates was assessed. The post Webinar: Scaling up IVT in mRNA production appeared first on Drug Discovery World (DDW). In this presentation, a review of the results from scaling up the IVT reaction from μg to gram scale mRNA yield will be presented.

Production 130

Production DNA Marketing Drugs 130

Drug Discovery World

JANUARY 19, 2023

This paid-for advertorial by Catalent appeared in DDW Volume 24 – Issue 1, Winter 2022/2023 One significant challenge in the manufacturing of cell and gene therapies is the production of high-quality plasmid DNA (pDNA). billion by 2030 (BioSpace, 11 August 2022). billion by 2030 (BioSpace, 11 August 2022).

DNA 130

DNA Therapies Assay Development Production 130

Drug Discovery World

SEPTEMBER 2, 2024

Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for next-generation antibody production. The event will feature Albert Zhang, Field Marketing & CRO Specialist at Fujifilm Wako.

Production 147

Production DNA Immune Response Pharmaceuticals 147

Drug Discovery World

AUGUST 26, 2024

In a webinar on 5 September, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, will present his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. The event is hosted by DDW and supported by Thermo Fisher Scientific.

Virus 162

Virus DNA Clinical Trials Engineering 162

Drug Discovery World

AUGUST 26, 2024

Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for next-generation antibody production. The event will feature Albert Zhang, Field Marketing & CRO Specialist at Fujifilm Wako.

DNA 147

DNA Immune Response Pharmaceuticals Production 147

Drug Discovery World

SEPTEMBER 2, 2024

In a webinar on 5 September, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, will present his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. The event is hosted by DDW and supported by Thermo Fisher Scientific.

Virus 130

Virus DNA Clinical Trials Engineering 130

Drug Discovery World

FEBRUARY 21, 2023

Memes, skits, science education, motivational quotes, podcast snippets, patient stories were all classified as educational/entertaining whereas company newsletter sign ups, employee life, awards/funding announcements, product highlights, conference attendance, and webinar invitations were all considered promotional content.

Marketing 130

Marketing Science DNA Laboratories 130

Agency IQ

APRIL 12, 2024

In drug development, biochemical assays might be used to determine a product’s binding affinity to a target receptor of interest, along with the strength, stability and duration of the target-ligand complex after the product binds to the receptor. morphological cell changes or alterations in protein production or expression).

Production 40

Production FDA Therapies Biochemical Assays 40

Elrig

APRIL 29, 2024

Webinar | Ai At The Frontier: Empowering Early Career Professionals In Drug Discovery WEBINAR – ARE YOU CURIOUS ABOUT THE CUTTING-EDGE INTERSECTION OF ARTIFICIAL INTELLIGENCE AND DRUG DISCOVERY? Are you curious about the cutting-edge intersection of Artificial Intelligence and Drug Discovery?

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.

Drug Development 52

Drug Development Treatment FDA Approval Drugs 52

Drug Discovery World

SEPTEMBER 29, 2023

The effect of several variables on the IVT reaction using different size DNA templates was assessed. The post Scaling up in vitro transcription: Key results and considerations appeared first on Drug Discovery World (DDW).

DNA 130

DNA Drugs 130

Drug Discovery World

AUGUST 1, 2023

The NIH states: “This natural mechanism for sequence-specific gene silencing promises to revolutionise experimental biology and may have important practical applications in functional genomics, therapeutic intervention, agriculture and other areas.” There are many examples of ways in which RNAi is impacting drug discovery.

RNA 130

RNA Vaccine Drugs Disease 130

Drug Discovery World

AUGUST 12, 2024

Join this engaging and informative webinar on Fujifilm Wako’s groundbreaking advancements in rabbit monoclonal antibody discovery. Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with its proprietary single B-cell cloning technique, paving the way for next-generation antibody production.

DNA 130

DNA Immune Response Production Drugs 130